The largest database of trusted experimental protocols

4 protocols using dspe peg 2000 ome

1

Liposomes Loaded with Everolimus

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOPC and DSPE-(PEG)2000-OMe were purchased from Avanti Polar Lipids and Nanosoft Polymers, respectively. Cholesterol was purchased from Sigma. Everolimus and EG00229 were obtained from LC laboratories and Tocris Bioscience, respectively. Ki67 (ab15880), PD-L1 (PA5-88105), β-actin (A2228), and YM1 (60130) antibodies were purchased from Abcam, Invitrogen, Sigma, and STEMCELL Technologies, respectively. The goat-anti-mouse PD-1 antibody was a kind gift from Dr. Keith L. Knutson (Mayo Clinic).
+ Open protocol
+ Expand
2

Nanomedicine Delivery Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOPC and DSPE-(PEG)2000-OMe were purchased from Avanti Polar Lipids and Nanosoft Polymers, respectively. Cholesterol was purchased from Sigma. TTP-conjugated lipopeptide was synthesized as described previously. Everolimus and YM155 were obtained from LC laboratories and MedChemExpress, respectively. Antibodies against mTOR, phospho-mTOR, p70S6K, phospho-p70S6K, survivin, ATM, PARP1, and β-actin were obtained from Cell Signaling Technology. ATR, CHk1, and Chk2 antibodies were obtained from Santa Cruz Biotechnology. CD3, CD8, and Ki67 antibodies were from Abcam, while CD45 antibody was from Biolegend.
+ Open protocol
+ Expand
3

Liposome Formulation for Cancer Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
DOPC and DSPE-PEG(2000)-OMe were purchased from Avanti Polar Lipids and Nanosoft Polymers, respectively. Cholesterol was purchased from Sigma. TTP-conjugated lipopeptide was synthesized as described previously [40] . Everolimus and cabozantinib were obtained from LC laboratories. YM155 and sunitinib were obtained from MedChemExpress and Selleckchem, respectively. Antibodies against mTOR, phospho-mTOR, p70S6K, phospho-p70S6K, survivin, ATM, PARP1, CD4, and β-actin were obtained from Cell Signaling Technology. ATR, Chk1, and Chk2 antibodies were obtained from Santa Cruz Biotechnology. CD3, CD8, and Ki67 antibodies were from Abcam, while CD45 antibody was from Biolegend. The phospho-p70S6K antibody used for immunohistochemistry was from Invitrogen. Purified anti-PD-1 antibody [42] was a kind gift from Dr. Keith L. Knutson (Mayo Clinic) who obtained it from the Antibody Core Facility at Mayo Clinic (Rochester, MN).
+ Open protocol
+ Expand
4

Lipid-Based Nanoparticle Delivery System for siRNA Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cholesterol was purchased from Chengdu Kelong Chemical Company (Chengdu, China). Soybean phospholipids (SPC) were purchased from Shanghai Taiwei Chemical Company (Shanghai, China). 1, 2-dioleoyl-3-trimethylammonium-propane (DOTAP) was obtained from Shanghai Advanced Vehicle Technology (AVT) Ltd. (Shanghai, China). DSPE-PEG2000-OMe and 1, 2-dioleoyl-sn-glycero-3- phosp-hoethanolamine-N-(carboxyfluorescein) (CFPE ) were purchased from Avanti Polar Lipids (Alabaster, AL, USA). Protamine sulfate (fraction X from salmon) and calf thymus DNA were purchased from Sigma-Aldrich (St. Louis, MO, USA). Paclitaxel (PTX) and low-molecular-weight heparin (Enoxaparin sodium, LH) were purchased from Melonepharma (Dalian, China). BCL-2 siRNA, scrambled siRNA and Cy5-labeled siRNA were purchased from Gene Pharma Ltd. (Shanghai, China). The BCL-2 siRNA (siBCL-2) sense sequence is 5'-GUG AUG AAG UAC AUC CAU UdTdT-3', and the anti-sense sequence is 5'-AAU GGA UGU ACU UCA UCA CdTdT-3'. The scramble siRNA (siCTL) sense sequence is 5'-UUC UCC GAA CGU GUC ACG UTT-3', and the anti-sense sequence is 5'-ACG UGA CAC GUU CGG AGA ATT-3'.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!